Bristlecone Advisors, LLC Abbott Laboratories Transaction History

Bristlecone Advisors, LLC

$1.24 Billion
Q3 2024

A detailed history of Bristlecone Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 2,043 shares of ABT stock, worth $243,014. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,043

Previous 2,198 7.05%

Holding current value

$243,014

Previous $228,000 1.75%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $15,510 - $18,310	-155 Reduced 7.05%	2,043 $232,000
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $26,491 - $29,571	-263 Reduced 10.69%	2,198 $228,000
Q1 2024 Apr 22, 2024	SELL	$109.52 - $120.96 $26,065 - $28,788	-238 Reduced 8.82%	2,461 $279,000
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $3,878 - $4,747	-43 Reduced 1.57%	2,699 $297,000
Q3 2023 Oct 16, 2023	SELL	$95.53 - $114.62 $11,463 - $13,754	-120 Reduced 4.19%	2,742 $265,000
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $32,249 - $35,932	-320 Reduced 10.06%	2,862 $312,000
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $242,150 - $285,025	-2,500 Reduced 44.0%	3,182 $322,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $950 - $1,115	10 Added 0.18%	5,682 $623,000
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $5,805 - $6,721	60 Added 1.07%	5,672 $549,000
Q2 2022 Jul 25, 2022	BUY	$102.07 - $123.37 $40,521 - $48,977	397 Added 7.61%	5,612 $610,000
Q4 2021 Jan 19, 2022	BUY	$115.53 - $141.46 $164,630 - $201,580	1,425 Added 37.6%	5,215 $734,000
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $5,289 - $6,226	-50 Reduced 1.3%	3,790 $439,000
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $13,440 - $14,645	-128 Reduced 3.23%	3,840 $420,000
Q3 2020 Oct 20, 2020	BUY	$91.64 - $111.29 $25,475 - $30,938	278 Added 7.53%	3,968 $432,000
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $21,056 - $26,950	-275 Reduced 6.94%	3,690 $337,000
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $202,657 - $296,340	-3,226 Reduced 44.86%	3,965 $313,000
Q4 2019 Jan 21, 2020	BUY	$78.51 - $87.4 $253,273 - $281,952	3,226 Added 81.36%	7,191 $625,000
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $264,015 - $286,275	-3,226 Reduced 44.86%	3,965 $332,000
Q2 2019 Jul 19, 2019	BUY	$72.88 - $85.0 $524,080 - $611,235	7,191 New	7,191 $605,000
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $263,224 - $318,238	-3,975 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$60.81 - $73.36 $241,719 - $291,606	3,975 New	3,975 $292,000
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $223,673 - $252,889	-3,975 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$48.06 - $53.64 $191,038 - $213,219	3,975	3,975 $212,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Abbott Laboratories Transaction History